PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biology, Faculty of Arts and Sciences, American University of Beirut, Beirut, Lebanon.\', \'Department of Internal Medicine, Basingstoke & North Hampshire Hospital, Basingstoke, United Kingdom.\', \'Department of Biology, College of Science, United Arab Emirates University, Al-Ain, United Arab Emirates.\', \'Department of Medical Laboratory Sciences, College of Health Sciences, and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.\', \'Department of Biomedical Sciences, University of Sassari, Sassari, Italy.\', \'Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.\', \'Center for Infectious Disease Research (CIDR), Faculty of Medicine, American University of Beirut, Beirut, Lebanon.\', \'Biomedical Research Center, Q.U. Health, Qatar University, Doha, Qatar.\', \'Department of Basic Medical Sciences, College of Medicine, Q.U. Health. Qatar University, Doha, Qatar.\', \'Biomedical and Pharmaceutical Research Unit, Q.U. Health, Qatar University, Doha, Qatar.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.663586
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33859652
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all